<DOC>
	<DOCNO>NCT01245374</DOCNO>
	<brief_summary>This study conduct Europe . The aim study compare easiness use Norditropin NordiFlex速 device device previously use patient parent .</brief_summary>
	<brief_title>Norditropin NordiFlex速 Device Compared Device Previously Used Patients Parents</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Children receive Norditropin速 ( somatropin ) treatment accord product labelling Treated growth hormone least one year Contraindications Norditropin速 growth hormone therapy Known suspect hypersensitivity somatropin relate product The receipt investigational medicinal product within 3 month prior study start Life threaten disease , example cancer Pregnancy intention become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>